Krakstad C et al. |
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. |
2006 |
Cell Death Differ. |
pmid:16311514
|
Blankson H et al. |
Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, naringin. |
2000 |
Cell Death Differ. |
pmid:10918448
|
Ahmad SF et al. |
Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines. |
2014 |
Cell. Immunol. |
pmid:24487035
|
Seto E et al. |
Patch clamp recording of the responses to three bitter stimuli in mouse taste cells. |
1999 |
Cell. Mol. Biol. (Noisy-le-grand) |
pmid:10386788
|
Shaik N et al. |
Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. |
2012 |
Cell. Physiol. Biochem. |
pmid:22854627
|
Jagetia GC and Reddy TK |
Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro. |
2011 |
Chem. Biol. Interact. |
pmid:21345335
|
Ozyürek M et al. |
Novel oxime based flavanone, naringin-oxime: synthesis, characterization and screening for antioxidant activity. |
2014 |
Chem. Biol. Interact. |
pmid:24508591
|
Amudha K and Pari L |
Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. |
2011 |
Chem. Biol. Interact. |
pmid:21600195
|
Dai H et al. |
A highly sensitive and selective sensing ECL platform for naringin based on β-Cyclodextrin functionalized carbon nanohorns. |
2011 |
Chem. Commun. (Camb.) |
pmid:21975830
|
Maehashi K et al. |
Riboflavin-binding protein is a novel bitter inhibitor. |
2008 |
Chem. Senses |
pmid:17846099
|
Gong HL et al. |
Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats. |
2012 |
Chin J Integr Med |
pmid:22936325
|
Wang JN et al. |
Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis. |
2012 |
Chin J Integr Med |
pmid:23239001
|
Caccamese S et al. |
Chiral HPLC separation and CD spectra of the C-2 diastereomers of naringin in grapefruit during maturation. |
2003 |
Chirality |
pmid:12923803
|
Jung UJ et al. |
Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. |
2003 |
Clin Nutr |
pmid:14613759
|
Jeon SM et al. |
Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. |
2004 |
Clin Nutr |
pmid:15380892
|
Bailey DG et al. |
Grapefruit juice and drugs. How significant is the interaction? |
1994 |
Clin Pharmacokinet |
pmid:8162660
|
Jeon SM et al. |
Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. |
2002 |
Clin. Chim. Acta |
pmid:11814474
|
Jagetia GC et al. |
Influence of naringin on ferric iron induced oxidative damage in vitro. |
2004 |
Clin. Chim. Acta |
pmid:15313158
|
Ballard TL et al. |
Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16620293
|
Bailey DG et al. |
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. |
2007 |
Clin. Pharmacol. Ther. |
pmid:17301733
|
Bailey DG et al. |
Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. |
1993 |
Clin. Pharmacol. Ther. |
pmid:8275614
|
Bailey DG et al. |
Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin. |
1993 |
Clin. Pharmacol. Ther. |
pmid:8513655
|
Bailey DG et al. |
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. |
2000 |
Clin. Pharmacol. Ther. |
pmid:11103749
|
Bailey DG et al. |
Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9757148
|
Yamakawa Y et al. |
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21633340
|
Luo Z et al. |
Effects of pH on the ability of flavonoids to act as Pickering emulsion stabilizers. |
2012 |
Colloids Surf B Biointerfaces |
pmid:22197223
|
Parmar HS et al. |
DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. |
2012 |
Diabetes Res. Clin. Pract. |
pmid:22410395
|
Drewnowski A et al. |
Genetic taste markers and food preferences. |
2001 |
Drug Metab. Dispos. |
pmid:11259346
|
Miyazaki N et al. |
Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats. |
2013 |
Drug Metab. Pharmacokinet. |
pmid:23419354
|
Shirasaka Y et al. |
Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. |
2011 |
Drug Metab. Pharmacokinet. |
pmid:21206133
|
Lambev I et al. |
[Antiexudative effect of naringin in experimental pulmonary edema and peritonitis]. |
1980 |
Eksp Med Morfol |
pmid:7460808
|
Oki K et al. |
The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. |
2012 |
Endocrinology |
pmid:22798349
|
Liu M et al. |
Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats. |
2011 |
Environ. Toxicol. Pharmacol. |
pmid:21787720
|
Nowak-Solinska E et al. |
The effect of naringin on early growth and development of the spheno-occipital synchondrosis as measured by the expression of PTHrP and Sox9--an in vitro model. |
2013 |
Eur J Orthod |
pmid:23172577
|
Sansone F et al. |
Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. |
2009 |
Eur J Pharm Biopharm |
pmid:18996478
|
Mielczarek C |
Acid-base properties of selected flavonoid glycosides. |
2005 |
Eur J Pharm Sci |
pmid:15911223
|
Rebello S et al. |
Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. |
2012 |
Eur. J. Clin. Pharmacol. |
pmid:22124880
|
Runkel M et al. |
Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man. |
1996 |
Eur. J. Clin. Pharmacol. |
pmid:8737764
|
Runkel M et al. |
The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human. |
1997 |
Eur. J. Clin. Pharmacol. |
pmid:9476043
|
Gaur V et al. |
Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. |
2009 |
Eur. J. Pharmacol. |
pmid:19577560
|
Wu JB et al. |
Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. |
2008 |
Eur. J. Pharmacol. |
pmid:18495116
|
Kawaguchi K et al. |
Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. |
1999 |
Eur. J. Pharmacol. |
pmid:10193661
|
Nie YC et al. |
Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways. |
2012 |
Eur. J. Pharmacol. |
pmid:22766066
|
Pari L and Amudha K |
Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. |
2011 |
Eur. J. Pharmacol. |
pmid:20950607
|
Zhang P et al. |
Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. |
2009 |
Eur. J. Pharmacol. |
pmid:19326565
|
Walker AL et al. |
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. |
2011 |
Exp. Hematol. |
pmid:21256917
|
Oliva J et al. |
Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. |
2008 |
Exp. Mol. Pathol. |
pmid:18793633
|
Ang ES et al. |
Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation. |
2011 |
FEBS Lett. |
pmid:21835177
|
Iqbal MF and Zhu WY |
Bioactivation of flavonoid diglycosides by chicken cecal bacteria. |
2009 |
FEMS Microbiol. Lett. |
pmid:19473248
|
Manzanares P et al. |
Purification and characterization of an alpha-L-rhamnosidase from Aspergillus niger. |
1997 |
FEMS Microbiol. Lett. |
pmid:9435109
|